EXPANDED ACCESS

Oncofibro is collaborating with licensed medical centre partners to offer Krysaygio™ in the following countries:

• Landmark Medical Centre, Johor Bahru, Malaysia
• Singapore Specialists Medical Centre, Cambodia

PBMC isolation and cell processing are performed by our manufacturing partner, Esco Aster, based in Singapore.

Krysaygio™ is currently undergoing registration in Bangkok, Thailand, based on its conditional approval in Japan.

For patients in Singapore, please contact us for information regarding eligibility and informed consent. All inquiries will be referred to our panel of authorized physicians.

If you are a clinician or cancer centre keen to join our expanded access / compassionate usage as a collaborator do reach out to us as well.